Soler, Nicolette, Cordier, Reinie, Perkes, Iain E., Dale, Russell C., Bray, Paula. Wiley-Blackwell; 2023. Proxy-reported sensory measures for children and adolescents with neurodevelopmental disorders: A systematic review.

Bukhari, Wajih, Prain, Kerri M., Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace J., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Waters, Patrick, Dale, Russell C., Woodhall, Mark, Lechner-Scott, Jeannette, O'Gorman, Cullen M., Clarke, Laura, Silvestrini, Roger A., Bundell, Christine S., Abernethy, David, Bhuta, Sandeep. BMJ Group; 2017. Incidence and prevalence of NMOSD in Australia and New Zealand.

Ramanathan, Sudarshini, Mohammad, Shekeeb, Henderson, Andrew P. D., Barnett, Michael Harry, Reddel, Stephen W., Brilot, Fabienne, Dale, Russell C., Tantsis, Esther, Nguyen, Tina Kim, Merheb, Vera, Fung, Victor S. C., White, Owen Bruce, Broadley, Simon, Lechner-Scott, Jeannette, Vucic, Steve. British Medical Journal (BMJ); 2018. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.

Tea, Fiona, Lopez, Joseph A., Tantsis, Esther M., Yiu, Eppie M., Vucic, Steve, Henderson, Andrew P. D., Fok, Anthony, Fraser, Clare L., Lechner-Scott, Jeanette, Reddel, Stephen W., Broadley, Simon, Barnett, Michael H., Ramanathan, Sudarshini, Brown, David A., Lunemann, Jan D., Dale, Russell C., Brilot, Fabienne, Australasian and New Zealand MOG Study Group,, Merheb, Vera, Lee, Fiona X. Z., Zou, Alicia, Pilli, Deepti, Patrick, Ellis, van der Walt, Anneke, Monif, Mastura. Biomed Central (BMC); 2019. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.

Trewin, Benjamin P., Dale, Russell C., van der Walt, Anneke, Lechner-Scott, Jeanette, Butzkueven, Helmut, Broadley, Simon A., Barnett, Michael H., Reddel, Stephen W., Brilot, Fabienne, Kalincik, Tomas, Ramanathan, Sudarshini, Qiu, Jessica, Chu, Melissa, Jeyakumar, Niroshan, Dela Cruz, Fionna, Andersen, Jane, Siriratnam, Pakeeran, Ma, Kit Kwan M., Hardy, Todd A.. BMJ Group; 2024. Oral corticosteroid dosage and tapeduration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse.